Current medical management of stable coronary artery disease before and after elective percutaneous coronary intervention
作者: Amer K. ArdatiBertram PittDean E. SmithHerbert D. AronowDavid ShareMauro MoscucciStanley ChetcutiP. Michael GrossmanHitinder S. Gurm
作者单位: 1Division of Cardiovascular Medicine, University of Illinois, Chicago, IL
2Division of Cardiovascular Medicine, University of Michigan, Ann Arbor, MI
3Division of Cardiovascular Medicine, St Joseph Mercy Hospital, Heart and Vascular Institute, Ann Arbor, MI
4Department of Family Medicine, University of Michigan, Ann Arbor, MI
5Cardiovascular Division, Department of Medicine, University of Miami, Miami, FL
刊名: American Heart Journal, 2013, Vol.165 (5), pp.778-784
来源数据库: Elsevier Journal
DOI: 10.1016/j.ahj.2013.01.015
原始语种摘要: Background(#br)Percutaneous coronary intervention (PCI) for stable coronary artery disease (CAD) is not superior to optimal medical therapy. It remains unclear if patients who receive PCI for stable CAD are receiving appropriate medical therapy.(#br)Methods(#br)We evaluated the medical management of 60,386 patients who underwent PCI for stable CAD between 2004 and 2009. We excluded patients with contraindications to aspirin, clopidogrel, statins, or β-blockers (BBs). We defined essential medical therapy of stable CAD as treatment with aspirin, statin, and BB before PCI and treatment with aspirin, clopidogrel, and statin after PCI.(#br)Results(#br)Essential medical therapy was used in 53.0% of patients before PCI and 82.1% at discharge. Aspirin was used in 94.8% patients before PCI and...
全文获取路径: Elsevier  (合作)
影响因子:4.497 (2012)

  • intervention 
  • coronary 冠状的
  • medical 医学
  • stable 稳定的
  • aspirin 阿司匹林
  • elective 选择的
  • after 在之后
  • percutaneous 经皮的
  • PCI Peripheral Component Interconnection
  • artery 动脉